Wilmington, United States
Charles River Laboratories, founded in 1947, stands as a resilient entity in the Biotechnology, Health Care, and Pharmaceutical industries. With its slogan, "Together, We Create Healthier Lives," the company emphasizes its commitment to advancing healthcare solutions by focusing on drug discovery, animal care, and environmental stewardship.
Headquartered in the United States, Charles River Laboratories continues to play a pivotal role in the development of therapeutics, underscoring their significance in both the global biotech landscape and local economies. They draw strength from their dedicated workforce, ensuring that their mission-driven initiatives are backed by passion and expertise.
The company's latest financial move was a Post Ipo Debt investment on 01 December 2024. Although no specific investors were disclosed, this strategic investment likely aims to enhance operational capabilities and foster innovation in their existing and future ventures.
Peptris Technologies
Galatea Bio Inc.